DNA & Genetics What the FDA’s Priority Voucher Decision Means for Psychedelic Drug DevelopmentBy adminFebruary 24, 20260 Credit: Alfred Pasieka/Science Photo Library/Getty Images The FDA Commissioner’s National Priority Review Voucher (CNPV) Pilot Program was created to accelerate…
DNA & Genetics What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening SessionBy adminOctober 3, 20250 The US Food and Drug Administration’s Office of Therapeutic Products (OTP) convened a public listening session on September 18, 2025,…
